PetMed Express, Inc. (PETS) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by PetMed Express, Inc. on October 21, 2025, covering events occurring on October 19 and October 20, 2025. The filing details significant changes to the Company's Board of Directors and executive leadership structure.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on corporate governance and executive compensation arrangements.
Material Changes
- Board Appointment: James LaCamp was appointed as a Director effective October 19, 2025. He immediately joined the Audit Committee and Compensation and Human Capital Committee, with a scheduled start as Audit Committee Chair on October 30, 2025. Mr. LaCamp is designated as an "audit committee financial expert."
- Executive Leadership: The Board approved an Interim Executive Employment Agreement with Leslie C.G. Campbell, formalizing her role as Interim Chief Executive Officer and President.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or discussion of risks and contingencies related to operations. Management commentary is limited to the rationale for Mr. LaCamp's appointment, citing his approximately 20 years of experience in finance, accounting, and audit, including roles as CFO at Skydio, Inc. and Flock Safety, and as a Partner at Deloitte & Touche LLP.
Executive Compensation Details
- Interim CEO Compensation: Leslie C.G. Campbell will receive an annual base salary of $1.3 million. The agreement is for a one-year term (August 11, 2025, to August 10, 2026) on an at-will basis with no severance compensation payable upon termination.
- Director Compensation: James LaCamp will be compensated in accordance with the Company's existing Non-Employee Director Compensation Program.
Key Facts for Investor Verification
- Verify the full text of the Interim Executive Employment Agreement (Exhibit 10.1) for specific restrictive covenants and termination clauses.
- Confirm the composition of the Audit Committee following Mr. LaCamp's appointment and his qualification as a financial expert.
- Review the Company's 2025 Form 10-K (filed October 14, 2025) for the specific details of the Non-Employee Director Compensation Program applicable to Mr. LaCamp.
- Note that the Interim CEO role is at-will with no severance, which may impact leadership stability assessments.